Stay updated on Efficacy Safety of Sintilimab IBI310 in EBV Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Efficacy Safety of Sintilimab IBI310 in EBV Gastric Cancer Clinical Trial page.

Latest updates to the Efficacy Safety of Sintilimab IBI310 in EBV Gastric Cancer Clinical Trial page
- Check4 days agoChange DetectedUpdated the page from v3.0.1 to v3.0.2 and removed the 'Back to Top' link.SummaryDifference0.8%
- Check11 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.8%
- Check18 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location, while several location-related terms have been removed.SummaryDifference5%
- Check25 days agoNo Change Detected
- Check33 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.3%
- Check40 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.3%
- Check47 days agoChange DetectedThe page has been updated to reflect a new version, v2.16.10, and the previous service alert regarding planned maintenance has been removed.SummaryDifference5%
Stay in the know with updates to Efficacy Safety of Sintilimab IBI310 in EBV Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy Safety of Sintilimab IBI310 in EBV Gastric Cancer Clinical Trial page.